158 related articles for article (PubMed ID: 25837468)
1. In vitro investigation of self-assembled nanoparticles based on hyaluronic acid-deoxycholic acid conjugates for controlled release doxorubicin: effect of degree of substitution of deoxycholic acid.
Wei WH; Dong XM; Liu CG
Int J Mol Sci; 2015 Mar; 16(4):7195-209. PubMed ID: 25837468
[TBL] [Abstract][Full Text] [Related]
2. Self-aggregated nanoparticles of carboxylic curdlan-deoxycholic acid conjugates as a carrier of doxorubicin.
Yan JK; Ma HL; Chen X; Pei JJ; Wang ZB; Wu JY
Int J Biol Macromol; 2015 Jan; 72():333-40. PubMed ID: 25193095
[TBL] [Abstract][Full Text] [Related]
3. Self-assembled nanoparticles based on chondroitin sulfate-deoxycholic acid conjugates for docetaxel delivery: Effect of degree of substitution of deoxycholic acid.
Liu M; Du H; Zhai G
Colloids Surf B Biointerfaces; 2016 Oct; 146():235-44. PubMed ID: 27343846
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin release from self-assembled nanoparticles of deoxycholic acid-conjugated dextran.
Jeong YI; Chung KD; Choi KC
Arch Pharm Res; 2011 Jan; 34(1):159-67. PubMed ID: 21468928
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of hyaluronic acid-anchored PLGA nanoparticulate carriers of doxorubicin.
Yadav AK; Mishra P; Mishra AK; Mishra P; Jain S; Agrawal GP
Nanomedicine; 2007 Dec; 3(4):246-57. PubMed ID: 18068091
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
[TBL] [Abstract][Full Text] [Related]
8. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
9. pH-sensitive chitosan-derived nanoparticles as doxorubicin carriers for effective anti-tumor activity: preparation and in vitro evaluation.
Jin YH; Hu HY; Qiao MX; Zhu J; Qi JW; Hu CJ; Zhang Q; Chen DW
Colloids Surf B Biointerfaces; 2012 Jun; 94():184-91. PubMed ID: 22405470
[TBL] [Abstract][Full Text] [Related]
10. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
Zhang J; Chen XG; Li YY; Liu CS
Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.
Zhou H; Yu W; Guo X; Liu X; Li N; Zhang Y; Ma X
Biomacromolecules; 2010 Dec; 11(12):3480-6. PubMed ID: 21028798
[TBL] [Abstract][Full Text] [Related]
12. Angelica sinensis polysaccharide nanoparticles as a targeted drug delivery system for enhanced therapy of liver cancer.
Zhang Y; Cui Z; Mei H; Xu J; Zhou T; Cheng F; Wang K
Carbohydr Polym; 2019 Sep; 219():143-154. PubMed ID: 31151511
[TBL] [Abstract][Full Text] [Related]
13. Novel hyaluronic acid coated hydrophobically modified chitosan polyelectrolyte complex for the delivery of doxorubicin.
Chen L; Zheng Y; Feng L; Liu Z; Guo R; Zhang Y
Int J Biol Macromol; 2019 Apr; 126():254-261. PubMed ID: 30584933
[TBL] [Abstract][Full Text] [Related]
14. Reduction-sensitive micelles self-assembled from amphiphilic chondroitin sulfate A-deoxycholic acid conjugate for triggered release of doxorubicin.
Liu H; Wu S; Yu J; Fan D; Ren J; Zhang L; Zhao J
Mater Sci Eng C Mater Biol Appl; 2017 Jun; 75():55-63. PubMed ID: 28415498
[TBL] [Abstract][Full Text] [Related]
15. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid.
Wang X; Gu X; Wang H; Yang J; Mao S
Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965
[TBL] [Abstract][Full Text] [Related]
16. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
17. Mulberry-like dual-drug complicated nanocarriers assembled with apogossypolone amphiphilic starch micelles and doxorubicin hyaluronic acid nanoparticles for tumor combination and targeted therapy.
Li K; Liu H; Gao W; Chen M; Zeng Y; Liu J; Xu L; Wu D
Biomaterials; 2015 Jan; 39():131-44. PubMed ID: 25477180
[TBL] [Abstract][Full Text] [Related]
18. All-trans retinoic acid-incorporated nanoparticles of deoxycholic acid-conjugated dextran for treatment of CT26 colorectal carcinoma cells.
Jeong YI; Chung KD; Kim DH; Kim YH; Lee YS; Choi KC
Int J Nanomedicine; 2013; 8():485-93. PubMed ID: 23390366
[TBL] [Abstract][Full Text] [Related]
19. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery.
Thambi T; You DG; Han HS; Deepagan VG; Jeon SM; Suh YD; Choi KY; Kim K; Kwon IC; Yi GR; Lee JY; Lee DS; Park JH
Adv Healthc Mater; 2014 Nov; 3(11):1829-38. PubMed ID: 24753360
[TBL] [Abstract][Full Text] [Related]
20. Adriamycin-incorporated nanoparticles of deoxycholic acid-conjugated dextran: antitumor activity against CT26 colon carcinoma.
Park KB; Jeong YL; Choi KC; Kim SG; Kim HK
J Nanosci Nanotechnol; 2011 May; 11(5):4240-9. PubMed ID: 21780435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
